Bo Cheng

560 total citations
17 papers, 350 citations indexed

About

Bo Cheng is a scholar working on Surgery, Immunology and Molecular Biology. According to data from OpenAlex, Bo Cheng has authored 17 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 6 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Bo Cheng's work include Pancreatitis Pathology and Treatment (3 papers), Macrophage Migration Inhibitory Factor (3 papers) and Esophageal Cancer Research and Treatment (2 papers). Bo Cheng is often cited by papers focused on Pancreatitis Pathology and Treatment (3 papers), Macrophage Migration Inhibitory Factor (3 papers) and Esophageal Cancer Research and Treatment (2 papers). Bo Cheng collaborates with scholars based in China, United States and Australia. Bo Cheng's co-authors include Wenlu Li, Quanbo Zhou, Minghua Ge, Youhua Jiang, Yanna Liu, Yanyan Liu, Juan Gao, Wei Ge, Changju Zhu and Yong Gao and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Scientific Reports and World Journal of Gastroenterology.

In The Last Decade

Bo Cheng

17 papers receiving 343 citations

Peers

Bo Cheng
Zhiyong Cai China
Peilun Ding China
Yansong Pu China
Cunzao Wu China
Yasuhiko Mitsuke Japan
Yoichiro Takami Japan
Shaohua Ren China
Yaping Dong China
Zhiyong Cai China
Bo Cheng
Citations per year, relative to Bo Cheng Bo Cheng (= 1×) peers Zhiyong Cai

Countries citing papers authored by Bo Cheng

Since Specialization
Citations

This map shows the geographic impact of Bo Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Cheng more than expected).

Fields of papers citing papers by Bo Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Cheng. The network helps show where Bo Cheng may publish in the future.

Co-authorship network of co-authors of Bo Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Cheng. A scholar is included among the top collaborators of Bo Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Cheng. Bo Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhang, Mei, et al.. (2023). Clinical Value Analysis of Serum TK1, SCC-Ag, and MUC-1 in the Diagnosis and Prognosis Evaluation of Cervical Cancer.. PubMed. 29(8). 788–792. 2 indexed citations
2.
Liu, Yanyan, Yanna Liu, Sanyang Chen, et al.. (2021). MIF inhibitor ISO-1 alleviates severe acute pancreatitis-associated acute kidney injury by suppressing the NLRP3 inflammasome signaling pathway. International Immunopharmacology. 96. 107555–107555. 30 indexed citations
3.
Zhang, Yan, et al.. (2021). Serum soluble suppression of tumorigenicity 2 as a novel inflammatory marker predicts the severity of acute pancreatitis. World Journal of Gastroenterology. 27(38). 6489–6500. 7 indexed citations
4.
He, Zhenyan, Linh Lieu, Yanbin Dong, et al.. (2021). PERK in POMC neurons connects celastrol with metabolism. JCI Insight. 6(18). 16 indexed citations
5.
Cheng, Bo, et al.. (2021). The inhibitory effect of human DEFA5 in growth of gastric cancer by targeting BMI1. Cancer Science. 112(3). 1075–1083. 19 indexed citations
6.
Zhu, Changju, Yanna Liu, Yanyan Liu, et al.. (2020). Deletion of macrophage migration inhibitory factor ameliorates inflammation in mice model severe acute pancreatitis. Biomedicine & Pharmacotherapy. 125. 109919–109919. 14 indexed citations
7.
Cheng, Bo, Yanna Liu, Yanyan Liu, et al.. (2020). MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo. Scientific Reports. 10(1). 6741–6741. 26 indexed citations
8.
9.
Cheng, Bo, Weihang Gao, Xiaojie Wu, et al.. (2020). Ginsenoside Rg2 Ameliorates High-Fat Diet-Induced Metabolic Disease through SIRT1. Journal of Agricultural and Food Chemistry. 68(14). 4215–4226. 47 indexed citations
10.
Chen, Xi, Zehong Yang, Huiling Hu, et al.. (2019). Differentiation and Proliferation of Intestinal Stem Cells and its Underlying Regulated Mechanisms during Weaning. Current Protein and Peptide Science. 20(7). 690–695. 6 indexed citations
11.
Jiang, Youhua, Bo Cheng, Minghua Ge, & Gu Zhang. (2012). The prognostic significance of p63 and Ki-67 expression in myoepithelial carcinoma. Head & Neck Oncology. 4(1). 9–9. 15 indexed citations
12.
Cheng, Bo, et al.. (2009). Expression and significance of endostatin,VEGF and MVD in renal cell carcinoma. Shandong yiyao. 49(22). 10–12. 1 indexed citations
13.
Jiang, Youhua, et al.. (2009). Comparison of the Clinical and Immunohistochemical Features, Including Anaplastic Lymphoma Kinase (ALK) and p53, in Inflammatory Myofibroblastic Tumours. Journal of International Medical Research. 37(3). 867–877. 29 indexed citations
14.
Cheng, Bo, et al.. (2007). Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions. International Journal of Clinical Practice. 61(3). 444–448. 22 indexed citations
15.
Cheng, Bo, et al.. (2005). Surgical treatment for upper or middle esophageal carcinoma occurring after gastrectomy: a study of 52 cases. Diseases of the Esophagus. 18(4). 239–245. 16 indexed citations
16.
Wang, Xinyun, Juhong Yang, Ying Ma, et al.. (2003). [Expression and significance of matrix metalloproteinases and their tissue inhibitors in the infiltration and metastasis of lung cancer].. PubMed. 6(4). 278–82. 2 indexed citations
17.
Cheng, Bo, et al.. (2000). Colon Interposition. Recent results in cancer research. 155. 151–160. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiyong Cai Breakdown of academic impact, for papers by Peilun Ding Breakdown of academic impact, for papers by Yansong Pu Breakdown of academic impact, for papers by Cunzao Wu Breakdown of academic impact, for papers by Yasuhiko Mitsuke Breakdown of academic impact, for papers by Yoichiro Takami Breakdown of academic impact, for papers by Shaohua Ren Breakdown of academic impact, for papers by Yaping Dong
Rankless by CCL
2026